{
    "clinical_study": {
        "@rank": "102458", 
        "arm_group": {
            "arm_group_label": "Embolization", 
            "arm_group_type": "Other", 
            "description": "Prostate artery embolization"
        }, 
        "brief_summary": {
            "textblock": "To evaluate whether Prostatic Artery Embolization (PAE) might be an effective alternative\n      treatment option for benign prostatic hyperplasia (BPH), in comparison to current gold\n      standard surgical treatment- Transurethral Resection of Prostate (TURP)."
        }, 
        "brief_title": "Prostatic Artery Embolization for Benign Prostatic Hyperplasia", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Benign Prostate Hyperplasia", 
        "condition_browse": {
            "mesh_term": [
                "Prostatic Hyperplasia", 
                "Hyperplasia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Moderate to severe lower urinary tract symptoms (i.e. International prostate symptom\n             score IPSS>8) who are bothered by their symptoms (i.e., interfere with the daily\n             activities of living)\n\n          2. Urinary retention (related to BPH) leading to catheterization.\n\n          3. Refractory to medical treatment or patient is not willing to consider medical\n             treatment\n\n          4. Pre trans-urethral resection of prostate (TURP) to reduce the size of prostate gland\n             if prostate is too big for TURP surgery.\n\n        Exclusion Criteria:\n\n          1. Mild symptoms (IPSS <8)\n\n          2. Moderate to severe lower urinary tract symptoms (i.e. IPSS>8) who are not bothered by\n             their symptoms (i.e., symptoms do not interfere with the daily activities of living).\n\n          3. Suspected malignancy.\n\n          4. Any of the following clearly related to BPH- bladder stones, recurrent UTIs, and\n             renal insufficiency.\n\n          5. Advanced atherosclerosis and unsuitable vascular access.\n\n          6. Allergy to intravenous contra"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01835860", 
            "org_study_id": "REB-12-81"
        }, 
        "intervention": {
            "arm_group_label": "Embolization", 
            "intervention_name": "Prostate artery embolization", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "BPH", 
        "lastchanged_date": "April 16, 2013", 
        "location": {
            "contact": {
                "email": "patanjali_c@hotmail.com", 
                "last_name": "Patanjali Chaturvedi, FRCPC", 
                "phone": "1(306)-7663715"
            }, 
            "facility": {
                "address": {
                    "city": "Regina", 
                    "country": "Canada", 
                    "state": "Saskatchewan", 
                    "zip": "S4P 0W5"
                }, 
                "name": "Regina General Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Patanjali Chaturvedi, FRCPC", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Ahmed Farooq, FRCPC", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Abdussalam Abujhar, FRCPC", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Erwin Karreman, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "June Zimmer, PhD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Lorna Montanini", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "patanjali_c@hotmail.com", 
            "last_name": "Patanjali Chaturvedi, FRCPC", 
            "phone": "1(306)-7663715"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Ethics Review Committee"
        }, 
        "phase": "Phase 2/Phase 3", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in symptom severity at 1, 3, 6 and 12 months follow-up, as measured by International prostate symptoms score (IPSS).", 
            "safety_issue": "No", 
            "time_frame": "1, 3, 6 and 12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01835860"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Regina Qu'Appelle Health Region", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Regina Qu'Appelle Health Region", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}